Last updated on November 2016

Descriptive Study of a Management Strategy for Mild to Moderate Major Depression: Combination of Rhodiola and Saffron Extracts.


Brief description of study

The purpose of the study is to describe, over 6 weeks, the evolution of depressive symptoms in patients with mild to moderate major depression in a strategy with Phytostandard® Rhodiola-Saffron supplementation

Detailed Study Description

For this study, 52 patients are going to be included. They will have a supplementation of Phytostandard® rhodiola/saffron, from 2 tablets per day during 42 days. on the one hand, during the two visits (inclusion and follow-up), the investigator completes the Hamilton Depression Scale (HAM-D) and the Clinical Global Impression (CGI). During the inclusion visit, he completes with his patient CIM-10 for depression diagnostic. on the other hand, patients complete HAD 4 times : just after the inclusion visit, at day 14, at day 28 and just before the follow-up visit. He completes the Patient Global Impression too at each time.

Clinical Study Identifier: NCT02981225

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Bastien Deyra

Pileje
Paris, France
  Connect »